enrofloxacin has been researched along with Infections, Salmonella in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Huang, L; Liu, Z; Pan, Y; Qu, W; Tao, Y; Xie, S; Yang, F; Yuan, Z | 1 |
| Dickson, J; Holtkamp, D; Hurd, HS; Vaughn, MB; Warnick, L | 1 |
| Ertelt, JM; Johanns, TM; Kalekar, LA; Law, CY; O'Donnell, H; Rowe, JH; Way, SS | 1 |
| Delsol, AA; Roe, JM; Woodward, MJ | 1 |
| Cebula, TA; Levy, DD; Sharma, B | 1 |
| Davis, S; Ewbank, AJ; Threlfall, EJ; Wall, PG; Ward, LR | 1 |
| Barry, J; Egan, J; Hill, M; McFaddyen, S; McNamara, E; Murphy, TM; O'Connell, A; O'Loughlin, J; Rooney, N | 1 |
7 other study(ies) available for enrofloxacin and Infections, Salmonella
| Article | Year |
|---|---|
Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular Salmonella.
Topics: Anti-Bacterial Agents; Drug Delivery Systems; Enrofloxacin; Fatty Acids; Fluoroquinolones; Humans; Lipids; Nanoparticles; Salmonella; Salmonella Infections | 2017 |
Quantitative risk from fluoroquinolone-resistant Salmonella and Campylobacter due to treatment of dairy heifers with enrofloxacin for bovine respiratory disease.
Topics: Animals; Campylobacter Infections; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Foodborne Diseases; Humans; Meat; Respiratory Tract Diseases; Risk Factors; Salmonella Infections | 2010 |
Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Enrofloxacin; Female; Fluoroquinolones; Immunity, Humoral; Male; Mice; Mice, Inbred C57BL; Salmonella; Salmonella Infections; Time Factors | 2011 |
Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cyclohexanes; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; Feces; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Quinolones; Salmonella enterica; Salmonella Infections; Swine | 2004 |
Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Base Pair Mismatch; Chloramphenicol; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Probes; DNA Repair; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Polymorphism, Single Nucleotide; Quinolones; Salmonella enterica; Salmonella Infections | 2004 |
Chronic carriage of multidrug resistant Salmonella typhimurium in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Drug Resistance, Microbial; Drug Resistance, Multiple; Enrofloxacin; Feces; Female; Fluoroquinolones; Gastroenteritis; Quinolones; Salmonella Infections; Salmonella typhimurium | 1995 |
Epidemiological studies of human and animal Salmonella typhimurium DT104 and DT104b isolates in Ireland.
Topics: Animals; Anti-Infective Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Fluoroquinolones; Humans; Ireland; Microbial Sensitivity Tests; Nalidixic Acid; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella Infections; Salmonella Infections, Animal; Salmonella typhimurium | 2001 |